Diagnostics Virtual Summit
|28th October 2020||Online||Event Website|
Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) testing are transforming diagnostics. New products and support services are providing the critical tools and components which enable clinicians to detect specific biomarkers and target treatments, ultimately resulting in better patient outcomes.
Abingdon Health’s Jonathan Thomas, Head of Contract Sales, joined the Cytiva Diagnostic virtual summit panel, with a focus on the long-term benefits of partnering with a dedicated lateral flow rapid test manufacturer and at what stage involving a CMO will ensure the successful transition from development in to routine manufacture.
Panel discussion also includes: